Senate Appropriations Committee Votes to Renew Protections for #MedicalMarijuana
Amendment would continue to prevent Dept. of Justice from using funds to target medical marijuana patients and providers in states where it is legal
* Statement below from Don Murphy of the Marijuana Policy Project *
WASHINGTON - July 27, 2017 (Investorideas.com Newswire) On Thursday, the Senate Appropriations Committee on Commerce, Justice, Science, and Related Agencies (CJS) approved an amendment in a voice vote that would continue to protect state medical marijuana programs from federal interference.
The amendment, introduced by Sen. Patrick Leahy (D-Vermont), would add a clause to the CJS budget for Fiscal Year 2018 that prevents the Dept. of Justice from using resources to prosecute medical marijuana patients and providers that are in compliance with state law. A similar amendment was introduced in the House of Representatives by Rep. Dana Rohrabacher (R-CA) and Rep. Earl Blumenauer (D-OR).
In 2014, Congress added a similar amendment to an omnibus spending bill that prevented the Dept. of Justice from spending any resources to target state-legal medical marijuana businesses. This amendment was subsequently renewed, but now stands to expire.
If the CJS budget is approved in the Senate, the amendment will go to a special conference committee to reach a compromise with the House. If no budget is approved by September 30, the previous amendment will be automatically renewed for another year.
Attorney General Jeff Sessions has repeatedly stated that he opposes marijuana being legal for any reason, and in May sent a letter to Congress urging them to vote down the amendment and allow him to resume prosecuting medical marijuana providers.
Twenty-nine states, the District of Columbia, and the U.S. territories of Guam and Puerto Rico have enacted effective medical marijuana laws.
According to an April poll conducted by Quinnipiac University, 94 percent of U.S. voters support allowing adults to legally use marijuana for medical purposes. The same poll showed 73 percent of U.S. voters "oppose government enforcement of federal laws against marijuana in states that have legalized medical or recreational marijuana."
Statement from Don Murphy, director of conservative outreach for the Marijuana Policy Project:
"More than half the states have taken a stand and said they want their seriously ill residents to have safe and reliable access to medical marijuana, and today the Senate Appropriations Committee listened. What was expected to be a very successful vote passed on an overwhelming voice vote, while opposition to the Leahy amendment was literally a whimper. That sound we heard in the Senate was the sound of a waving white flag as the federal war on medical marijuana patients and providers winds down.
"We strongly urge the rest of Congress to do the right thing and include this amendment in the final budget. Even if you are one of the few people who don't support medical marijuana, states should still have the right to help their most vulnerable residents. They should not have to worry about the Department of Justice interfering."
The Marijuana Policy Project is the nation's largest marijuana policy organization. For more information, visit http://www.MarijuanaPolicy.org.
Don Murphy, Director of Conservative Outreach
Like Marijuana Stocks? View our Marijuana / Hemp Stocks Directory
Join our Group on Linkedin - Marijuana / Hemp Stocks - News and Trends in Green Investing
Watch the 420 Cannabis Investor video
This news is published on the Investorideas.com Newswire - a global digital news source for investors and business leaders
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release on the Investorideas.com newswire https://www.investorideas.com/News-Upload/
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: https://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.